| Bioactivity | SARS-CoV-2 3CLpro-IN-25 (compound 56) inhibits the SARS-CoV-2 3CLpro with the IC50 of 70 nM and displays antiviral activity in cells with the EC50 of 3.1 μM[1]. |
| Formula | C17H14N2O3S |
| Molar Mass | 326.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fatima-Zahra Chaibi, et al. N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease. Eur J Med Chem. 2024 Oct 5:276:116707. |
SARS-CoV-2 3CLpro-IN-25
CAS: F: C17H14N2O3S W: 326.37
SARS-CoV-2 3CLpro-IN-25 (compound 56) inhibits the SARS-CoV-2 3CLpro with the IC50 of 70 nM and displays antiviral activ
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.